Detalhe da pesquisa
1.
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults.
Nat Commun
; 14(1): 1138, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878897
2.
Safety and immunogenicity of the adjunct therapeutic vaccine ID93â+âGLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.
Lancet Respir Med
; 9(4): 373-386, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306991
3.
A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.
Vaccine
; 38(7): 1700-1707, 2020 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899025
4.
The adjuvant GLA-AF enhances human intradermal vaccine responses.
Sci Adv
; 4(9): eaas9930, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30221194